

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.25982588 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.25982588 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.19658118 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.11273963 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.06349350 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.03029349 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 5.03029349 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.98059619 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 4.98059619 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.71274869 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.70414293 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 4.60200308 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 4.56181424 |
| 14 | glyoxylate metabolic process (GO:0046487) | 4.49342787 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.46702607 |
| 16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.37122467 |
| 17 | lysine metabolic process (GO:0006553) | 4.36862801 |
| 18 | lysine catabolic process (GO:0006554) | 4.36862801 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.36487283 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.36487283 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.36487283 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.36487283 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.36487283 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 4.36487283 |
| 25 | kynurenine metabolic process (GO:0070189) | 4.34066883 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 4.28548763 |
| 27 | detection of other organism (GO:0098543) | 4.28079370 |
| 28 | detection of bacterium (GO:0016045) | 4.27389337 |
| 29 | protein carboxylation (GO:0018214) | 4.24815440 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.24815440 |
| 31 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.24707921 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.17443166 |
| 33 | tryptophan catabolic process (GO:0006569) | 4.16055023 |
| 34 | indole-containing compound catabolic process (GO:0042436) | 4.16055023 |
| 35 | indolalkylamine catabolic process (GO:0046218) | 4.16055023 |
| 36 | cysteine metabolic process (GO:0006534) | 4.11380270 |
| 37 | negative regulation of fibrinolysis (GO:0051918) | 4.03649064 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 3.97233154 |
| 39 | tryptophan metabolic process (GO:0006568) | 3.95135014 |
| 40 | urea metabolic process (GO:0019627) | 3.95001175 |
| 41 | urea cycle (GO:0000050) | 3.95001175 |
| 42 | neutrophil activation involved in immune response (GO:0002283) | 3.94784470 |
| 43 | bile acid biosynthetic process (GO:0006699) | 3.88563728 |
| 44 | high-density lipoprotein particle remodeling (GO:0034375) | 3.83195550 |
| 45 | regulation of protein activation cascade (GO:2000257) | 3.80388428 |
| 46 | response to peptidoglycan (GO:0032494) | 3.76973143 |
| 47 | plasma lipoprotein particle clearance (GO:0034381) | 3.76724935 |
| 48 | amino-acid betaine metabolic process (GO:0006577) | 3.73359855 |
| 49 | leukocyte aggregation (GO:0070486) | 3.68686665 |
| 50 | regulation of fibrinolysis (GO:0051917) | 3.66604813 |
| 51 | nitrogen cycle metabolic process (GO:0071941) | 3.65484558 |
| 52 | valine metabolic process (GO:0006573) | 3.63115722 |
| 53 | regulation of complement activation (GO:0030449) | 3.61895842 |
| 54 | phospholipid efflux (GO:0033700) | 3.61712403 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 3.61479731 |
| 56 | negative regulation of sterol transport (GO:0032372) | 3.61479731 |
| 57 | regulation of cholesterol homeostasis (GO:2000188) | 3.60247864 |
| 58 | macrophage activation involved in immune response (GO:0002281) | 3.57299990 |
| 59 | detection of external biotic stimulus (GO:0098581) | 3.56883011 |
| 60 | homocysteine metabolic process (GO:0050667) | 3.55888624 |
| 61 | serine family amino acid catabolic process (GO:0009071) | 3.55272124 |
| 62 | ethanol oxidation (GO:0006069) | 3.53114413 |
| 63 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.48681629 |
| 64 | 2-oxoglutarate metabolic process (GO:0006103) | 3.46478018 |
| 65 | regulation of gamma-delta T cell activation (GO:0046643) | 3.44697860 |
| 66 | reverse cholesterol transport (GO:0043691) | 3.44650821 |
| 67 | fatty acid beta-oxidation (GO:0006635) | 3.42155836 |
| 68 | positive regulation of lipid catabolic process (GO:0050996) | 3.40073074 |
| 69 | regulation of cholesterol esterification (GO:0010872) | 3.38950406 |
| 70 | protein-lipid complex remodeling (GO:0034368) | 3.32897788 |
| 71 | macromolecular complex remodeling (GO:0034367) | 3.32897788 |
| 72 | plasma lipoprotein particle remodeling (GO:0034369) | 3.32897788 |
| 73 | phospholipid homeostasis (GO:0055091) | 3.32514102 |
| 74 | bile acid metabolic process (GO:0008206) | 3.31849953 |
| 75 | mannose metabolic process (GO:0006013) | 3.29792927 |
| 76 | fatty acid oxidation (GO:0019395) | 3.27262823 |
| 77 | acylglycerol homeostasis (GO:0055090) | 3.27234530 |
| 78 | triglyceride homeostasis (GO:0070328) | 3.27234530 |
| 79 | cellular extravasation (GO:0045123) | 3.23002734 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 3.21981923 |
| 81 | lipid oxidation (GO:0034440) | 3.20956788 |
| 82 | alpha-amino acid catabolic process (GO:1901606) | 3.19702105 |
| 83 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.18910551 |
| 84 | aromatic amino acid family metabolic process (GO:0009072) | 3.18909534 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.18549098 |
| 86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.18549098 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 3.18263630 |
| 88 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.17495633 |
| 89 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.16564939 |
| 90 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.13123303 |
| 91 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.11988652 |
| 92 | acetyl-CoA metabolic process (GO:0006084) | 3.11827904 |
| 93 | detection of biotic stimulus (GO:0009595) | 3.11121567 |
| 94 | carnitine metabolic process (GO:0009437) | 3.07232989 |
| 95 | regulation of mast cell degranulation (GO:0043304) | 3.07146546 |
| 96 | immunoglobulin mediated immune response (GO:0016064) | 3.06885269 |
| 97 | positive thymic T cell selection (GO:0045059) | 3.06666735 |
| 98 | protein-lipid complex assembly (GO:0065005) | 3.06404634 |
| 99 | low-density lipoprotein particle clearance (GO:0034383) | 3.06229291 |
| 100 | glycine metabolic process (GO:0006544) | 3.06217442 |
| 101 | fatty acid catabolic process (GO:0009062) | 3.05857056 |
| 102 | detection of molecule of bacterial origin (GO:0032490) | 3.05528837 |
| 103 | cellular ketone body metabolic process (GO:0046950) | 3.04751895 |
| 104 | short-chain fatty acid metabolic process (GO:0046459) | 3.04703544 |
| 105 | aspartate family amino acid catabolic process (GO:0009068) | 3.04003354 |
| 106 | cholesterol efflux (GO:0033344) | 3.03606863 |
| 107 | tyrosine metabolic process (GO:0006570) | 3.03582304 |
| 108 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.03316858 |
| 109 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.03129931 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.01566399 |
| 111 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.00463362 |
| 112 | cellular amino acid catabolic process (GO:0009063) | 3.00217487 |
| 113 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.99253905 |
| 114 | fibrinolysis (GO:0042730) | 2.99180173 |
| 115 | sterol homeostasis (GO:0055092) | 2.98765665 |
| 116 | monocarboxylic acid catabolic process (GO:0072329) | 2.98168401 |
| 117 | benzene-containing compound metabolic process (GO:0042537) | 2.98141882 |
| 118 | regulation of leukocyte degranulation (GO:0043300) | 2.97662617 |
| 119 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.94842749 |
| 120 | cellular glucuronidation (GO:0052695) | 2.94820939 |
| 121 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.94634027 |
| 122 | serine family amino acid metabolic process (GO:0009069) | 2.94404909 |
| 123 | regulation of cholesterol storage (GO:0010885) | 2.93781027 |
| 124 | negative regulation of interleukin-12 production (GO:0032695) | 2.93170056 |
| 125 | fatty acid transmembrane transport (GO:1902001) | 2.93099418 |
| 126 | response to muramyl dipeptide (GO:0032495) | 2.93027878 |
| 127 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.91158868 |
| 128 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.90234348 |
| 129 | neutrophil activation (GO:0042119) | 2.89797292 |
| 130 | acute-phase response (GO:0006953) | 2.88965782 |
| 131 | germinal center formation (GO:0002467) | 2.88880606 |
| 132 | bile acid and bile salt transport (GO:0015721) | 2.86850163 |
| 133 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.86783425 |
| 134 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.86750020 |
| 135 | response to host immune response (GO:0052572) | 2.86750020 |
| 136 | positive regulation of fatty acid oxidation (GO:0046321) | 2.86509523 |
| 137 | ethanol metabolic process (GO:0006067) | 2.86441324 |
| 138 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.86405895 |
| 139 | lipoprotein metabolic process (GO:0042157) | 2.85861994 |
| 140 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.84946435 |
| 141 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.84912798 |
| 142 | response to host (GO:0075136) | 2.84912798 |
| 143 | response to host defenses (GO:0052200) | 2.84912798 |
| 144 | regulation of triglyceride metabolic process (GO:0090207) | 2.84383625 |
| 145 | complement activation (GO:0006956) | 2.82751579 |
| 146 | carboxylic acid catabolic process (GO:0046395) | 2.82444199 |
| 147 | organic acid catabolic process (GO:0016054) | 2.82444199 |
| 148 | response to interleukin-15 (GO:0070672) | 2.82283402 |
| 149 | regulation of cholesterol metabolic process (GO:0090181) | 2.81066357 |
| 150 | response to laminar fluid shear stress (GO:0034616) | 2.80868361 |
| 151 | tricarboxylic acid metabolic process (GO:0072350) | 2.79126106 |
| 152 | indolalkylamine metabolic process (GO:0006586) | 2.78222591 |
| 153 | drug transmembrane transport (GO:0006855) | 2.77932380 |
| 154 | negative regulation of phagocytosis (GO:0050765) | 2.77896485 |
| 155 | plasma lipoprotein particle organization (GO:0071827) | 2.77747803 |
| 156 | respiratory burst (GO:0045730) | 2.76544846 |
| 157 | regulation of T cell tolerance induction (GO:0002664) | 2.74669178 |
| 158 | thymic T cell selection (GO:0045061) | 2.72130446 |
| 159 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.71094228 |
| 160 | pinocytosis (GO:0006907) | 2.70291292 |
| 161 | regulation of extracellular matrix disassembly (GO:0010715) | 2.69498841 |
| 162 | granulocyte activation (GO:0036230) | 2.68366801 |
| 163 | B cell receptor signaling pathway (GO:0050853) | 2.67963899 |
| 164 | response to type I interferon (GO:0034340) | 2.67421162 |
| 165 | cellular response to type I interferon (GO:0071357) | 2.66322161 |
| 166 | type I interferon signaling pathway (GO:0060337) | 2.66322161 |
| 167 | negative regulation of innate immune response (GO:0045824) | 2.65816798 |
| 168 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.65745365 |
| 169 | negative thymic T cell selection (GO:0045060) | 2.64865082 |
| 170 | regulation of tolerance induction (GO:0002643) | 2.61260023 |
| 171 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.61202710 |
| 172 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.58946877 |
| 173 | T cell selection (GO:0045058) | 2.58625660 |
| 174 | myeloid cell activation involved in immune response (GO:0002275) | 2.51338517 |
| 175 | macrophage activation (GO:0042116) | 2.48949076 |
| 176 | positive regulation of B cell differentiation (GO:0045579) | 2.48532514 |
| 177 | negative T cell selection (GO:0043383) | 2.48470264 |
| 178 | barbed-end actin filament capping (GO:0051016) | 2.47026629 |
| 179 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.45814974 |
| 180 | negative regulation of T cell mediated immunity (GO:0002710) | 2.44850218 |
| 181 | negative regulation of type 2 immune response (GO:0002829) | 2.41098737 |
| 182 | regulation of regulated secretory pathway (GO:1903305) | 2.38869248 |
| 183 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.38131715 |
| 184 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.38131715 |
| 185 | NIK/NF-kappaB signaling (GO:0038061) | 2.37456420 |
| 186 | modulation by symbiont of host cellular process (GO:0044068) | 2.37113166 |
| 187 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.36873673 |
| 188 | regulation of superoxide anion generation (GO:0032928) | 2.36683131 |
| 189 | regulation of B cell differentiation (GO:0045577) | 2.36431557 |
| 190 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.34424298 |
| 191 | negative regulation of interleukin-6 production (GO:0032715) | 2.34345663 |
| 192 | modulation by virus of host process (GO:0019054) | 2.34314118 |
| 193 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.33708593 |
| 194 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.33417432 |
| 195 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.33219287 |
| 196 | regulation of antigen processing and presentation (GO:0002577) | 2.32963087 |
| 197 | microglial cell activation (GO:0001774) | 2.31194337 |
| 198 | tolerance induction (GO:0002507) | 2.31189703 |
| 199 | positive regulation of extracellular matrix organization (GO:1903055) | 2.30455426 |
| 200 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.30214469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.48790447 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.37725696 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.05712662 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.93785436 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.25775170 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.52461295 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.12130924 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.79643072 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.68401022 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.45143983 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.37444625 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.27165482 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.24014265 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.21408368 |
| 15 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.08509688 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.07809391 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.92402778 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90435343 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.87200963 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.79589305 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.74221553 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73208624 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67732351 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.63301189 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62909514 |
| 26 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.60667356 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59662440 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.59104968 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.56930331 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55083471 |
| 31 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.51870180 |
| 32 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.51352863 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.50900198 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50898160 |
| 35 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.50873015 |
| 36 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48972990 |
| 37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.48252962 |
| 38 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47250557 |
| 39 | * MYC_22102868_ChIP-Seq_BL_Human | 1.43462187 |
| 40 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43254399 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.42573385 |
| 42 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41361047 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.41280265 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.40575969 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40139198 |
| 46 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.38985408 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.38831500 |
| 48 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.38127818 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.36995085 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35970580 |
| 51 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.35903268 |
| 52 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.35282278 |
| 53 | * MAF_26560356_Chip-Seq_TH1_Human | 1.34954572 |
| 54 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.34578088 |
| 55 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.32884216 |
| 56 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31944229 |
| 57 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30293198 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.27174369 |
| 59 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26597316 |
| 60 | MYB_26560356_Chip-Seq_TH2_Human | 1.26484447 |
| 61 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26016677 |
| 62 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.25521270 |
| 63 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25462694 |
| 64 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.24975717 |
| 65 | P68_20966046_ChIP-Seq_HELA_Human | 1.22493612 |
| 66 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.21593413 |
| 67 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21460021 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19870799 |
| 69 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19419235 |
| 70 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19225560 |
| 71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19128745 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18754211 |
| 73 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18453829 |
| 74 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.15272906 |
| 75 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14932636 |
| 76 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14740023 |
| 77 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.14531403 |
| 78 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.14531403 |
| 79 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14242553 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14173279 |
| 81 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.13012192 |
| 82 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12646441 |
| 83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11915642 |
| 84 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10839578 |
| 85 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.10015703 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09105300 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08837392 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08836820 |
| 89 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08035269 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07336678 |
| 91 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07044510 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06815666 |
| 93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06692973 |
| 94 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05740193 |
| 95 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05553421 |
| 96 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04855326 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03815627 |
| 98 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02707168 |
| 99 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01859022 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01146832 |
| 101 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.00005927 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99917987 |
| 103 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99715972 |
| 104 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99250744 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97991814 |
| 106 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97355529 |
| 107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97326897 |
| 108 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.97149762 |
| 109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97130380 |
| 110 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96835747 |
| 111 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96635342 |
| 112 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95666035 |
| 113 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.94515919 |
| 114 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.93123516 |
| 115 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93016579 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90415638 |
| 117 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.90271277 |
| 118 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90235322 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88638046 |
| 120 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87129289 |
| 121 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.86647211 |
| 122 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.86443858 |
| 123 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86379114 |
| 124 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.84814612 |
| 125 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84656807 |
| 126 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83448255 |
| 127 | MAF_26560356_Chip-Seq_TH2_Human | 0.82351298 |
| 128 | * MYB_26560356_Chip-Seq_TH1_Human | 0.81344133 |
| 129 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.81191534 |
| 130 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79625367 |
| 131 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.78455284 |
| 132 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78098359 |
| 133 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.77757416 |
| 134 | SPI1_23127762_ChIP-Seq_K562_Human | 0.76031526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.30503078 |
| 2 | MP0005360_urolithiasis | 5.07095833 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.85131525 |
| 4 | MP0005365_abnormal_bile_salt | 3.85049085 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.05917286 |
| 6 | MP0009840_abnormal_foam_cell | 2.98141882 |
| 7 | MP0003252_abnormal_bile_duct | 2.84720304 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.63039588 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.62368467 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.49320940 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.42414914 |
| 12 | MP0005083_abnormal_biliary_tract | 2.28764942 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.14241123 |
| 14 | MP0008260_abnormal_autophagy | 2.04887187 |
| 15 | MP0005332_abnormal_amino_acid | 1.92602389 |
| 16 | MP0003763_abnormal_thymus_physiology | 1.87842490 |
| 17 | MP0001666_abnormal_nutrient_absorption | 1.87666143 |
| 18 | MP0005671_abnormal_response_to | 1.86243917 |
| 19 | MP0002723_abnormal_immune_serum | 1.85752985 |
| 20 | MP0002420_abnormal_adaptive_immunity | 1.84037274 |
| 21 | MP0003172_abnormal_lysosome_physiology | 1.82622982 |
| 22 | MP0001819_abnormal_immune_cell | 1.82292145 |
| 23 | MP0000609_abnormal_liver_physiology | 1.79673089 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.79239036 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.77669575 |
| 26 | MP0002132_abnormal_respiratory_system | 1.76744465 |
| 27 | MP0008438_abnormal_cutaneous_collagen | 1.72424556 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.70835653 |
| 29 | MP0003195_calcinosis | 1.69412465 |
| 30 | MP0003828_pulmonary_edema | 1.62781011 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.61570630 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.58831049 |
| 33 | MP0000858_altered_metastatic_potential | 1.58280453 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.58271436 |
| 35 | MP0002405_respiratory_system_inflammati | 1.57078693 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.52924759 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.51299751 |
| 38 | MP0003436_decreased_susceptibility_to | 1.50520005 |
| 39 | MP0002998_abnormal_bone_remodeling | 1.46391793 |
| 40 | MP0002398_abnormal_bone_marrow | 1.43316321 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.43116993 |
| 42 | MP0003866_abnormal_defecation | 1.43083309 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.41381808 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.40617219 |
| 45 | MP0004019_abnormal_vitamin_homeostasis | 1.40088066 |
| 46 | MP0000716_abnormal_immune_system | 1.39001016 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.37533331 |
| 48 | MP0001851_eye_inflammation | 1.30562008 |
| 49 | MP0003075_altered_response_to | 1.29070342 |
| 50 | MP0003303_peritoneal_inflammation | 1.28232058 |
| 51 | MP0005670_abnormal_white_adipose | 1.27027456 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.24992119 |
| 53 | MP0005058_abnormal_lysosome_morphology | 1.24636261 |
| 54 | MP0002933_joint_inflammation | 1.23782501 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.21519996 |
| 56 | MP0001873_stomach_inflammation | 1.21492627 |
| 57 | MP0005451_abnormal_body_composition | 1.20476074 |
| 58 | MP0004858_abnormal_nervous_system | 1.20109492 |
| 59 | MP0004130_abnormal_muscle_cell | 1.20078695 |
| 60 | MP0002722_abnormal_immune_system | 1.18560396 |
| 61 | MP0002837_dystrophic_cardiac_calcinosis | 1.18395202 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.18036571 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.16599422 |
| 64 | MP0002429_abnormal_blood_cell | 1.16414929 |
| 65 | MP0005666_abnormal_adipose_tissue | 1.14682831 |
| 66 | MP0003724_increased_susceptibility_to | 1.14252627 |
| 67 | MP0004883_abnormal_blood_vessel | 1.12534479 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.12371381 |
| 69 | MP0009278_abnormal_bone_marrow | 1.12154797 |
| 70 | MP0000598_abnormal_liver_morphology | 1.12052750 |
| 71 | MP0008469_abnormal_protein_level | 1.11415158 |
| 72 | MP0003091_abnormal_cell_migration | 1.10823043 |
| 73 | MP0005464_abnormal_platelet_physiology | 1.10423381 |
| 74 | MP0000685_abnormal_immune_system | 1.09567771 |
| 75 | MP0008004_abnormal_stomach_pH | 1.09536471 |
| 76 | MP0009764_decreased_sensitivity_to | 1.08689335 |
| 77 | MP0004381_abnormal_hair_follicle | 1.08434002 |
| 78 | MP0005164_abnormal_response_to | 1.07115420 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 1.06884122 |
| 80 | MP0003186_abnormal_redox_activity | 1.06209760 |
| 81 | MP0005166_decreased_susceptibility_to | 1.05866304 |
| 82 | MP0005390_skeleton_phenotype | 1.04246865 |
| 83 | MP0000703_abnormal_thymus_morphology | 1.04174534 |
| 84 | MP0001849_ear_inflammation | 1.03094156 |
| 85 | MP0001835_abnormal_antigen_presentation | 0.99828121 |
| 86 | MP0005409_darkened_coat_color | 0.99733428 |
| 87 | MP0005275_abnormal_skin_tensile | 0.98990007 |
| 88 | MP0009763_increased_sensitivity_to | 0.97651659 |
| 89 | MP0005023_abnormal_wound_healing | 0.97241446 |
| 90 | MP0006082_CNS_inflammation | 0.96054325 |
| 91 | MP0009785_altered_susceptibility_to | 0.95593061 |
| 92 | MP0003279_aneurysm | 0.95481930 |
| 93 | MP0005025_abnormal_response_to | 0.94110911 |
| 94 | MP0002254_reproductive_system_inflammat | 0.92770256 |
| 95 | MP0004947_skin_inflammation | 0.92039684 |
| 96 | MP0002419_abnormal_innate_immunity | 0.91065220 |
| 97 | MP0000343_altered_response_to | 0.88729539 |
| 98 | MP0001663_abnormal_digestive_system | 0.87456912 |
| 99 | MP0000490_abnormal_crypts_of | 0.86466894 |
| 100 | MP0004264_abnormal_extraembryonic_tissu | 0.86302310 |
| 101 | MP0001790_abnormal_immune_system | 0.85460423 |
| 102 | MP0005387_immune_system_phenotype | 0.85460423 |
| 103 | MP0001533_abnormal_skeleton_physiology | 0.84953617 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.84380297 |
| 105 | MP0003448_altered_tumor_morphology | 0.84375671 |
| 106 | MP0003690_abnormal_glial_cell | 0.84143403 |
| 107 | MP0002060_abnormal_skin_morphology | 0.84097879 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.83591052 |
| 109 | MP0005310_abnormal_salivary_gland | 0.82723747 |
| 110 | MP0001845_abnormal_inflammatory_respons | 0.81507822 |
| 111 | MP0002971_abnormal_brown_adipose | 0.81378338 |
| 112 | MP0003868_abnormal_feces_composition | 0.80402920 |
| 113 | MP0003795_abnormal_bone_structure | 0.80059093 |
| 114 | MP0005330_cardiomyopathy | 0.79980393 |
| 115 | MP0010630_abnormal_cardiac_muscle | 0.79950531 |
| 116 | MP0009053_abnormal_anal_canal | 0.78844561 |
| 117 | MP0001853_heart_inflammation | 0.78629096 |
| 118 | MP0001958_emphysema | 0.78215315 |
| 119 | MP0006054_spinal_hemorrhage | 0.77790936 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.76221764 |
| 121 | MP0000767_abnormal_smooth_muscle | 0.75865948 |
| 122 | MP0010155_abnormal_intestine_physiology | 0.75111856 |
| 123 | MP0001756_abnormal_urination | 0.74820635 |
| 124 | MP0000249_abnormal_blood_vessel | 0.73776641 |
| 125 | MP0005636_abnormal_mineral_homeostasis | 0.72857351 |
| 126 | MP0004084_abnormal_cardiac_muscle | 0.72186428 |
| 127 | MP0009642_abnormal_blood_homeostasis | 0.71391092 |
| 128 | MP0001800_abnormal_humoral_immune | 0.71330642 |
| 129 | MP0005375_adipose_tissue_phenotype | 0.71193454 |
| 130 | MP0004087_abnormal_muscle_fiber | 0.70492033 |
| 131 | MP0001764_abnormal_homeostasis | 0.70006707 |
| 132 | MP0003453_abnormal_keratinocyte_physiol | 0.69406059 |
| 133 | MP0005397_hematopoietic_system_phenotyp | 0.69301366 |
| 134 | MP0001545_abnormal_hematopoietic_system | 0.69301366 |
| 135 | MP0010352_gastrointestinal_tract_polyps | 0.68714748 |
| 136 | MP0000604_amyloidosis | 0.67999762 |
| 137 | MP0003011_delayed_dark_adaptation | 0.66854727 |
| 138 | MP0005334_abnormal_fat_pad | 0.66582371 |
| 139 | MP0004272_abnormal_basement_membrane | 0.65712702 |
| 140 | MP0002796_impaired_skin_barrier | 0.65286219 |
| 141 | MP0001879_abnormal_lymphatic_vessel | 0.64782238 |
| 142 | MP0009115_abnormal_fat_cell | 0.64130044 |
| 143 | MP0009384_cardiac_valve_regurgitation | 0.63421144 |
| 144 | MP0005385_cardiovascular_system_phenoty | 0.63297055 |
| 145 | MP0001544_abnormal_cardiovascular_syste | 0.63297055 |
| 146 | MP0001243_abnormal_dermal_layer | 0.62136243 |
| 147 | MP0004510_myositis | 0.62030109 |
| 148 | MP0002128_abnormal_blood_circulation | 0.61944725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.39503788 |
| 2 | Xanthomatosis (HP:0000991) | 4.67068025 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.49902795 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.48648699 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.33811510 |
| 6 | Complement deficiency (HP:0004431) | 4.14085551 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.12938332 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.07419407 |
| 9 | Myositis (HP:0100614) | 4.00773466 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 3.69769985 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 3.67122747 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.65484541 |
| 13 | Joint hemorrhage (HP:0005261) | 3.53457912 |
| 14 | Orchitis (HP:0100796) | 3.51987455 |
| 15 | Hyperammonemia (HP:0001987) | 3.50957377 |
| 16 | Hypoglycemic coma (HP:0001325) | 3.41988279 |
| 17 | Ketosis (HP:0001946) | 3.38970076 |
| 18 | Abnormality of complement system (HP:0005339) | 3.32788624 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.31025767 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.23526907 |
| 21 | Prolonged bleeding time (HP:0003010) | 3.16542894 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.16402776 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.15525877 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.14374873 |
| 25 | Hyperglycinuria (HP:0003108) | 3.13884259 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.11555187 |
| 27 | Increased IgE level (HP:0003212) | 3.10230212 |
| 28 | Hypolipoproteinemia (HP:0010981) | 3.06774683 |
| 29 | Myocardial infarction (HP:0001658) | 3.05383721 |
| 30 | Cellulitis (HP:0100658) | 3.00984210 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.00661226 |
| 32 | Obstructive lung disease (HP:0006536) | 3.00661226 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 3.00584618 |
| 34 | Purpura (HP:0000979) | 2.95726269 |
| 35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.91014723 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 2.90485099 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.90485099 |
| 38 | Gingivitis (HP:0000230) | 2.87468818 |
| 39 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.86621219 |
| 40 | Optic neuritis (HP:0100653) | 2.86393665 |
| 41 | Retrobulbar optic neuritis (HP:0100654) | 2.86393665 |
| 42 | Meningitis (HP:0001287) | 2.84186525 |
| 43 | Epidermoid cyst (HP:0200040) | 2.82448126 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.82144776 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.77532552 |
| 46 | Hypercholesterolemia (HP:0003124) | 2.72397596 |
| 47 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.70402858 |
| 48 | Recurrent fungal infections (HP:0002841) | 2.70316580 |
| 49 | Ketoacidosis (HP:0001993) | 2.68270170 |
| 50 | Hyperglycinemia (HP:0002154) | 2.63975781 |
| 51 | Abnormality of the intrinsic pathway (HP:0010989) | 2.59353487 |
| 52 | Recurrent skin infections (HP:0001581) | 2.55642924 |
| 53 | Fat malabsorption (HP:0002630) | 2.54566157 |
| 54 | Esophageal varix (HP:0002040) | 2.51548218 |
| 55 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.51083176 |
| 56 | Stomatitis (HP:0010280) | 2.49949140 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.46407750 |
| 58 | Pustule (HP:0200039) | 2.44651834 |
| 59 | Gastrointestinal inflammation (HP:0004386) | 2.43325263 |
| 60 | Vasculitis (HP:0002633) | 2.42869685 |
| 61 | Glomerulonephritis (HP:0000099) | 2.41638701 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.39358797 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.39358797 |
| 64 | Polycythemia (HP:0001901) | 2.38989258 |
| 65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.38680423 |
| 66 | Abnormality of nucleobase metabolism (HP:0010932) | 2.37103506 |
| 67 | Colitis (HP:0002583) | 2.36480446 |
| 68 | Petechiae (HP:0000967) | 2.36385797 |
| 69 | Urticaria (HP:0001025) | 2.36127878 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.34790296 |
| 71 | Hepatocellular carcinoma (HP:0001402) | 2.34462099 |
| 72 | Mitral stenosis (HP:0001718) | 2.33056260 |
| 73 | Dysostosis multiplex (HP:0000943) | 2.32232311 |
| 74 | Hyperbilirubinemia (HP:0002904) | 2.30570673 |
| 75 | Encephalitis (HP:0002383) | 2.27857971 |
| 76 | Hypochromic anemia (HP:0001931) | 2.23524335 |
| 77 | Chest pain (HP:0100749) | 2.23336971 |
| 78 | Right ventricular cardiomyopathy (HP:0011663) | 2.21373144 |
| 79 | Myoglobinuria (HP:0002913) | 2.20484797 |
| 80 | Peritonitis (HP:0002586) | 2.20347749 |
| 81 | Hemorrhage of the eye (HP:0011885) | 2.20328018 |
| 82 | Gout (HP:0001997) | 2.19718393 |
| 83 | Abnormality of methionine metabolism (HP:0010901) | 2.19224906 |
| 84 | Skin nodule (HP:0200036) | 2.18774890 |
| 85 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.18495017 |
| 86 | Spontaneous hematomas (HP:0007420) | 2.18332729 |
| 87 | Gingival bleeding (HP:0000225) | 2.18010517 |
| 88 | Keratoconjunctivitis sicca (HP:0001097) | 2.16891278 |
| 89 | Nephritis (HP:0000123) | 2.15815754 |
| 90 | Vascular calcification (HP:0004934) | 2.14742308 |
| 91 | Generalized aminoaciduria (HP:0002909) | 2.14673663 |
| 92 | Abnormal cartilage morphology (HP:0002763) | 2.13624867 |
| 93 | Autoimmune thrombocytopenia (HP:0001973) | 2.13529450 |
| 94 | Axonal loss (HP:0003447) | 2.13113690 |
| 95 | Late onset (HP:0003584) | 2.12531956 |
| 96 | Protrusio acetabuli (HP:0003179) | 2.12433388 |
| 97 | Increased cerebral lipofuscin (HP:0011813) | 2.11997541 |
| 98 | Spastic diplegia (HP:0001264) | 2.10452132 |
| 99 | Abnormality of the peritoneum (HP:0002585) | 2.09555102 |
| 100 | Cardiovascular calcification (HP:0011915) | 2.08926030 |
| 101 | Cerebral aneurysm (HP:0004944) | 2.08477934 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 2.08175653 |
| 103 | Metabolic acidosis (HP:0001942) | 2.07736210 |
| 104 | Vertebral compression fractures (HP:0002953) | 2.07728115 |
| 105 | Episodic fever (HP:0001954) | 2.06437052 |
| 106 | Increased connective tissue (HP:0009025) | 2.05306590 |
| 107 | Pulmonary infiltrates (HP:0002113) | 2.04444084 |
| 108 | Eczematoid dermatitis (HP:0000976) | 2.03716359 |
| 109 | Recurrent viral infections (HP:0004429) | 2.03512375 |
| 110 | Polygenic inheritance (HP:0010982) | 2.02301188 |
| 111 | Cholelithiasis (HP:0001081) | 2.02085672 |
| 112 | Asymmetric septal hypertrophy (HP:0001670) | 2.01433177 |
| 113 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.00264280 |
| 114 | Emphysema (HP:0002097) | 2.00124412 |
| 115 | Osteomyelitis (HP:0002754) | 1.99436222 |
| 116 | Thin bony cortex (HP:0002753) | 1.99102501 |
| 117 | Amyloidosis (HP:0011034) | 1.99101996 |
| 118 | Dilatation of the ascending aorta (HP:0005111) | 1.99098342 |
| 119 | Menorrhagia (HP:0000132) | 1.98694932 |
| 120 | Recurrent cutaneous fungal infections (HP:0011370) | 1.98375912 |
| 121 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.98375912 |
| 122 | Nausea (HP:0002018) | 1.97618171 |
| 123 | Increased serum ferritin (HP:0003281) | 1.97406417 |
| 124 | Abnormality of glycolipid metabolism (HP:0010969) | 1.97097662 |
| 125 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.97097662 |
| 126 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.97097662 |
| 127 | Lymphangioma (HP:0100764) | 1.96621692 |
| 128 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95172928 |
| 129 | Ventricular tachycardia (HP:0004756) | 1.93677214 |
| 130 | Hemoptysis (HP:0002105) | 1.93660701 |
| 131 | Arterial thrombosis (HP:0004420) | 1.93647429 |
| 132 | Delayed CNS myelination (HP:0002188) | 1.93110141 |
| 133 | Keratoconjunctivitis (HP:0001096) | 1.92693728 |
| 134 | Abnormality of proline metabolism (HP:0010907) | 1.92613242 |
| 135 | Hydroxyprolinuria (HP:0003080) | 1.92613242 |
| 136 | Loss of speech (HP:0002371) | 1.91688678 |
| 137 | Mucopolysacchariduria (HP:0008155) | 1.91222982 |
| 138 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91222982 |
| 139 | Abnormal gallbladder morphology (HP:0012437) | 1.91165245 |
| 140 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90546108 |
| 141 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90546108 |
| 142 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90546108 |
| 143 | Malnutrition (HP:0004395) | 1.89512592 |
| 144 | Steatorrhea (HP:0002570) | 1.88877458 |
| 145 | Gastrointestinal stroma tumor (HP:0100723) | 1.88587561 |
| 146 | Interstitial pulmonary disease (HP:0006530) | 1.87189193 |
| 147 | Thrombophlebitis (HP:0004418) | 1.85646027 |
| 148 | Increased mean platelet volume (HP:0011877) | 1.85353218 |
| 149 | Increased variability in muscle fiber diameter (HP:0003557) | 1.84824398 |
| 150 | Metaphyseal cupping (HP:0003021) | 1.84010247 |
| 151 | Rhabdomyolysis (HP:0003201) | 1.82454651 |
| 152 | Aneurysm (HP:0002617) | 1.82387952 |
| 153 | Abnormal platelet volume (HP:0011876) | 1.80702450 |
| 154 | Abnormality of the nasal mucosa (HP:0000433) | 1.80511476 |
| 155 | Hypochromic microcytic anemia (HP:0004840) | 1.80298402 |
| 156 | Hepatosplenomegaly (HP:0001433) | 1.79945218 |
| 157 | Granulocytopenia (HP:0001913) | 1.79763546 |
| 158 | Pancreatitis (HP:0001733) | 1.78716133 |
| 159 | Hypergammaglobulinemia (HP:0010702) | 1.78467344 |
| 160 | Abnormal platelet function (HP:0011869) | 1.77946190 |
| 161 | Impaired platelet aggregation (HP:0003540) | 1.77946190 |
| 162 | Aortic aneurysm (HP:0004942) | 1.77258914 |
| 163 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.77037399 |
| 164 | Hypertriglyceridemia (HP:0002155) | 1.76029339 |
| 165 | Neonatal onset (HP:0003623) | 1.73042561 |
| 166 | Broad metatarsal (HP:0001783) | 1.72202606 |
| 167 | Pulmonary embolism (HP:0002204) | 1.71275559 |
| 168 | Exercise-induced muscle cramps (HP:0003710) | 1.69610364 |
| 169 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.68340975 |
| 170 | Abnormality of the Achilles tendon (HP:0005109) | 1.67487672 |
| 171 | Epistaxis (HP:0000421) | 1.66688715 |
| 172 | Recurrent bacterial skin infections (HP:0005406) | 1.66517364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.26913754 |
| 2 | ERN1 | 4.24567837 |
| 3 | PKN2 | 3.46150443 |
| 4 | BCKDK | 3.24438585 |
| 5 | RIPK4 | 3.21822108 |
| 6 | PRPF4B | 3.08663755 |
| 7 | SIK1 | 2.68517628 |
| 8 | TTN | 2.54184841 |
| 9 | FGFR4 | 2.43105080 |
| 10 | MAP3K10 | 2.28469548 |
| 11 | MAP4K1 | 1.95313371 |
| 12 | PTK6 | 1.94033024 |
| 13 | SMG1 | 1.93770002 |
| 14 | TGFBR2 | 1.88703982 |
| 15 | EPHB1 | 1.86218345 |
| 16 | EEF2K | 1.84865391 |
| 17 | TYK2 | 1.76819139 |
| 18 | MAP3K13 | 1.75574286 |
| 19 | MAP2K3 | 1.74086502 |
| 20 | LRRK2 | 1.73417270 |
| 21 | TNK2 | 1.69308305 |
| 22 | TBK1 | 1.65825096 |
| 23 | FES | 1.59186715 |
| 24 | TAOK3 | 1.51991387 |
| 25 | RIPK1 | 1.50531242 |
| 26 | FLT3 | 1.47149678 |
| 27 | MST1R | 1.37502181 |
| 28 | BLK | 1.30550767 |
| 29 | STK10 | 1.30363281 |
| 30 | TESK2 | 1.28223762 |
| 31 | NEK9 | 1.27638764 |
| 32 | TIE1 | 1.24095335 |
| 33 | KDR | 1.22638317 |
| 34 | MAP3K1 | 1.20573370 |
| 35 | LATS1 | 1.16122264 |
| 36 | MARK2 | 1.15858840 |
| 37 | GRK6 | 1.15700829 |
| 38 | BMX | 1.15638759 |
| 39 | TAOK2 | 1.13283005 |
| 40 | KSR2 | 1.12828687 |
| 41 | CDC42BPA | 1.12756344 |
| 42 | CAMK1D | 1.11652707 |
| 43 | ZAP70 | 1.11410325 |
| 44 | MAP3K7 | 1.10686068 |
| 45 | JAK1 | 1.08355800 |
| 46 | CSK | 1.07214346 |
| 47 | SIK3 | 1.07080278 |
| 48 | FGR | 1.05316616 |
| 49 | JAK3 | 1.01383966 |
| 50 | MAP3K3 | 1.00277945 |
| 51 | SYK | 0.99311068 |
| 52 | MAPK11 | 0.99253038 |
| 53 | PDGFRA | 0.97608109 |
| 54 | PIK3CG | 0.97414280 |
| 55 | BTK | 0.96645469 |
| 56 | MYLK | 0.95137988 |
| 57 | JAK2 | 0.94642822 |
| 58 | CDK6 | 0.93393398 |
| 59 | CSF1R | 0.92576593 |
| 60 | MAP3K14 | 0.91119970 |
| 61 | IKBKE | 0.89615250 |
| 62 | MAP3K6 | 0.89517386 |
| 63 | IRAK3 | 0.88900862 |
| 64 | PDK1 | 0.88815132 |
| 65 | DMPK | 0.85184237 |
| 66 | KIT | 0.83801787 |
| 67 | RPS6KA4 | 0.82433915 |
| 68 | LYN | 0.81384366 |
| 69 | HIPK2 | 0.80015768 |
| 70 | LCK | 0.79259777 |
| 71 | CDK4 | 0.77119253 |
| 72 | STK3 | 0.77056489 |
| 73 | MAPK7 | 0.75812171 |
| 74 | PRKAA2 | 0.75535075 |
| 75 | EPHA3 | 0.73515166 |
| 76 | CDK12 | 0.73382054 |
| 77 | PAK4 | 0.73182368 |
| 78 | EPHB2 | 0.72225985 |
| 79 | NME2 | 0.71491776 |
| 80 | MAP3K11 | 0.70817347 |
| 81 | FGFR3 | 0.70471403 |
| 82 | STK4 | 0.70027262 |
| 83 | MTOR | 0.69589509 |
| 84 | TESK1 | 0.69518766 |
| 85 | MET | 0.68792273 |
| 86 | TRPM7 | 0.68523495 |
| 87 | ILK | 0.68521986 |
| 88 | MATK | 0.65198624 |
| 89 | PTK2 | 0.62990599 |
| 90 | RPS6KA2 | 0.62190272 |
| 91 | PRKD1 | 0.62104120 |
| 92 | IRAK2 | 0.61232181 |
| 93 | CAMK1G | 0.61002119 |
| 94 | IKBKB | 0.60833681 |
| 95 | TGFBR1 | 0.60809662 |
| 96 | SIK2 | 0.60536374 |
| 97 | ITK | 0.60151966 |
| 98 | MARK3 | 0.59849723 |
| 99 | ICK | 0.59626737 |
| 100 | CHUK | 0.59030874 |
| 101 | DYRK1B | 0.58983362 |
| 102 | TXK | 0.58056283 |
| 103 | STK38 | 0.57993629 |
| 104 | HCK | 0.56851302 |
| 105 | PIM1 | 0.55648276 |
| 106 | INSRR | 0.55072410 |
| 107 | MAP2K2 | 0.54437613 |
| 108 | PAK2 | 0.53736689 |
| 109 | LMTK2 | 0.53170352 |
| 110 | YES1 | 0.52852896 |
| 111 | MAP3K2 | 0.51928076 |
| 112 | GSK3A | 0.51524015 |
| 113 | ABL2 | 0.50919121 |
| 114 | MAPK12 | 0.50538574 |
| 115 | MAPKAPK2 | 0.49056171 |
| 116 | PRKG2 | 0.48530344 |
| 117 | CAMKK1 | 0.48075011 |
| 118 | FYN | 0.47273764 |
| 119 | MAP3K8 | 0.46755953 |
| 120 | TAOK1 | 0.46295836 |
| 121 | RPS6KA6 | 0.44987151 |
| 122 | MAPKAPK3 | 0.44561516 |
| 123 | PDGFRB | 0.44146365 |
| 124 | IRAK1 | 0.43933556 |
| 125 | OBSCN | 0.42537214 |
| 126 | PRKCH | 0.42324741 |
| 127 | PRKD2 | 0.41251952 |
| 128 | WNK4 | 0.41184333 |
| 129 | SGK3 | 0.40630350 |
| 130 | MAPK4 | 0.40169191 |
| 131 | PDPK1 | 0.39985350 |
| 132 | DDR2 | 0.39930584 |
| 133 | RPS6KL1 | 0.39453545 |
| 134 | RPS6KC1 | 0.39453545 |
| 135 | PIK3CA | 0.39002880 |
| 136 | RET | 0.37366102 |
| 137 | IRAK4 | 0.36509968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.46202487 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.09897171 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.04321849 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.92491468 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.81632950 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.52088458 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.51711819 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51192280 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.48797430 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.38839957 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.30507641 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19871776 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.10271135 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.09823118 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.07271674 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.99562294 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97133663 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.92520833 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.88223703 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87708867 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.82978771 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.73119710 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.70997263 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.67372101 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.64688343 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61700777 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.61495751 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60636731 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57258441 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.55700777 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.54365041 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.52222855 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.44628159 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.43988291 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41295503 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.40077080 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38519518 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.35613271 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.35308574 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.34990608 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.31649227 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29729431 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29504753 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.28219097 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.26690592 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26561106 |
| 47 | Lysine degradation_Homo sapiens_hsa00310 | 1.26460510 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.25817382 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.25714606 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25151973 |
| 51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.24920851 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 1.22454655 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 1.21705815 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 1.20792008 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.20043595 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.20032264 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18683410 |
| 58 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18363820 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17439905 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.17320192 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17121234 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15466604 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 1.13927458 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10030410 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07874423 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.06893170 |
| 67 | Hepatitis B_Homo sapiens_hsa05161 | 1.02984323 |
| 68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.01434774 |
| 69 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01211598 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00719257 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00425305 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00273639 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00207949 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99257753 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.97778452 |
| 76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.97570476 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96350485 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.94536848 |
| 79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93899234 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92965165 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87242228 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.85710690 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85246018 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84165324 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84149046 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.83645343 |
| 87 | Shigellosis_Homo sapiens_hsa05131 | 0.83459148 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83202277 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82745849 |
| 90 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81042049 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.78653823 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.77888882 |
| 93 | Salmonella infection_Homo sapiens_hsa05132 | 0.77488358 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76950417 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75640289 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75632005 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75570467 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.75248536 |
| 99 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73401285 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72151347 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71911291 |
| 102 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71679925 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71102430 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70754672 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69994599 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69843955 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69154418 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68227481 |
| 109 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66891482 |
| 110 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.66413979 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66317148 |
| 112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65854220 |
| 113 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62150408 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60007823 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58285484 |
| 116 | Leishmaniasis_Homo sapiens_hsa05140 | 0.57599837 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57459841 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57114202 |
| 119 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56963339 |
| 120 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56550638 |
| 121 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.55991454 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54857780 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.54512033 |
| 124 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51925252 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51862902 |
| 126 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51754557 |
| 127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51379243 |
| 128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50938486 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49730205 |
| 130 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46996139 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46769505 |
| 132 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46277319 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45575801 |
| 134 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44300880 |
| 135 | Amoebiasis_Homo sapiens_hsa05146 | 0.40012065 |
| 136 | Pertussis_Homo sapiens_hsa05133 | 0.38504319 |
| 137 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.37272838 |
| 138 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.37096664 |
| 139 | Malaria_Homo sapiens_hsa05144 | 0.34242398 |
| 140 | Legionellosis_Homo sapiens_hsa05134 | 0.33721978 |
| 141 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31717424 |
| 142 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30605649 |
| 143 | Lysosome_Homo sapiens_hsa04142 | 0.29879540 |
| 144 | Other glycan degradation_Homo sapiens_hsa00511 | 0.29726989 |
| 145 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.29685361 |
| 146 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.27939346 |
| 147 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.27745080 |
| 148 | Prion diseases_Homo sapiens_hsa05020 | 0.27576833 |
| 149 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27208383 |
| 150 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.23700768 |
| 151 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.23362385 |
| 152 | Viral myocarditis_Homo sapiens_hsa05416 | 0.23003268 |
| 153 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.21785396 |
| 154 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20954456 |
| 155 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.20669919 |
| 156 | Focal adhesion_Homo sapiens_hsa04510 | 0.20612754 |
| 157 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20380271 |
| 158 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.19036382 |
| 159 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.18692420 |
| 160 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.17771024 |
| 161 | Hepatitis C_Homo sapiens_hsa05160 | 0.16684974 |
| 162 | Measles_Homo sapiens_hsa05162 | 0.15868102 |
| 163 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15273979 |
| 164 | Bladder cancer_Homo sapiens_hsa05219 | 0.15059082 |

